BackStructure Therapeutics Overview

Structure Therapeutics Long Term Debt

Structure Therapeutics's long-term debt is $3.6M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$3.63M
63.76% YoYΔ $-6.39M vs prior year quarter

Peer average / median

Loading

Structure Therapeutics Long Term Debt History

Loading

Structure Therapeutics vs. peers: Long Term Debt Comparison

Loading

Structure Therapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Structure Therapeutics (GPCR) FAQ

As of the most recent data (June 2026), GPCR shows a long-term debt of $3.6M. That compares with $10M in the prior-year period — down 63.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GPCR's long-term debt is now $3.6M (was $10M) — a 63.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Structure Therapeutics is outperforming or lagging.

Tracking GPCR's long-term debt over time shows whether Structure Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $3.6M That compares with $10M in the prior-year period — down 63.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Structure Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $3.6M) with ownership activity and broader fundamentals.